English cross-cultural translation and validation of the neuromuscular score: a system for motor function classification in patients with neuromuscular diseases

Archive ouverte

Vuillerot, Carole | Meilleur, K. G. | Jain, M. | Waite, M. | Wu, T. | Linton, M. | Datsgir, J. | Donkervoort, S. | Leach, M. E. | Rutkowski, A. | Rippert, P. | Payan, C. | Iwaz, J. | Hamroun, D. | Berard, C. | Poirot, I. | Bonnemann, C. G.

Edité par CCSD ; Elsevier -

International audience. Objective: To develop and validate an English version of the Neuromuscular (NM)-Score, a classification for patients with NM diseases in each of the 3 motor function domains: D1, standing and transfers; D2, axial and proximal motor function; and D3, distal motor function.Design: Validation survey.Setting: Patients seen at a medical research center between June and September 2013.Participants: Consecutive patients (N=42) aged 5 to 19 years with a confirmed or suspected diagnosis of congenital muscular dystrophy.Interventions: Not applicable.Main Outcome Measures: An English version of the NM-Score was developed by a 9-person expert panel that assessed its content validity and semantic equivalence. Its concurrent validity was tested against criterion standards (Brooke Scale, Motor Function Measure [MFM], activity limitations for patients with upper and/or lower limb impairments [ACTIVLIM], Jebsen Test, and myometry measurements). Informant agreement between patient/caregiver (P/C)-reported and medical doctor (MD)-reported NM scores was measured by weighted kappa.Results: Significant correlation coefficients were found between NM scores and criterion standards. The highest correlations were found between NM-score D1 and MFM score D1 (rho =-.944, P<.0001), ACTIVLIM (rho =-.895, P<.0001), and hip abduction strength by myometry (rho =-.811, P<.0001). Informant agreement between P/C-reported and MD-reported NM scores was high for D1 (kappa=.801; 95% confidence interval [CI],.701-.914) but moderate for D2 (kappa=.592; 95% CI,.412-.773) and D3 (kappa =.485; 95% CI,.290-.680). Correlation coefficients between the NM scores and the criterion standards did not significantly differ between P/C-reported and MD-reported NM scores.Conclusions: Patients and physicians completed the English NM-Score easily and accurately. The English version is a reliable and valid instrument that can be used in clinical practice and research to describe the functional abilities of patients with NM diseases.

Consulter en ligne

Suggestions

Du même auteur

Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy

Archive ouverte | Vuillerot, Carole | CCSD

International audience. Objectives: To monitor treatment effects in patients with congenital myopathies and congenital muscular dystrophies, valid outcome measures are necessary. The Motor Function Measure (MFM) was...

Influence of a two-year steroid treatment on body composition as measured by dual X-ray absorptiometry in boys with Duchenne muscular dystrophy

Archive ouverte | Vuillerot, Carole | CCSD

International audience

Development and validation of a motor function classification in patients with neuromuscular disease: the NM-score

Archive ouverte | Vuillerot, C. | CCSD

International audience

Chargement des enrichissements...